ReviewFrontiers in molecular biosciences2022

Regulation of the HBV Entry Receptor NTCP and its Potential in Hepatitis B Treatment.

Yan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.